https://clinicaltrials.gov/ct2/show/NCT03251092?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=06%2F04%2F2019&lupd_d=14
Conditions : Healthy Volunteer – Complete; Cystic Fibrosis
Interventions : Drug: PTI-808; Drug: Placebo; Drug: PTI-428; Drug: PTI-801
Sponsor : Proteostasis Therapeutics, Inc.
Recruiting
Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis
NCT03251092
Wed, 16 Aug 2017 12:00:00 EDT
Last Update Posted: 06/18/19 07:04AM
